Study Title: Peri-operative Immuno-Chemotherapy in Operable Oesophageal and Gastric Cancer (ICONIC Trial)
Phase of Trial: Phase II
Latest Information Update: 14 Feb 2018
At a glance
- Drugs Avelumab (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- Acronyms ICONIC
- 08 Feb 2018 Planned number of patients changed from 38 to 40.
- 08 Feb 2018 Planned End Date changed from 30 Oct 2024 to 15 Aug 2025.
- 08 Feb 2018 Planned primary completion date changed from 30 Jul 2020 to 15 Apr 2021.